Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995971 citationsJon Kobashigawa, S Katznelson et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of N. Kawata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Kawata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Kawata more than expected).
This network shows the impact of papers produced by N. Kawata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Kawata. The network helps show where N. Kawata may publish in the future.
Co-authorship network of co-authors of N. Kawata
This figure shows the co-authorship network connecting the top 25 collaborators of N. Kawata.
A scholar is included among the top collaborators of N. Kawata based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with N. Kawata. N. Kawata is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Kobashigawa, Jon, L W Stevenson, Erica Brownfield, et al.. (1996). Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.. PubMed. 14(5). 963–7.27 indexed citations
10.
Kobashigawa, Jon, S Katznelson, Hillel Laks, et al.. (1995). Effect of Pravastatin on Outcomes after Cardiac Transplantation. New England Journal of Medicine. 333(10). 621–627.971 indexed citations breakdown →
11.
Kobashigawa, Jon, Hillel Laks, Gregg C. Fonarow, et al.. (1995). The University of California at Los Angeles experience in heart transplantation.. PubMed. 129–10.10 indexed citations
Kobashigawa, Jon, B. Lennart Johnson, J. Moriguchi, et al.. (1993). Influenza vaccine does not cause rejection after cardiac transplantation.. PubMed. 25(4). 2738–9.34 indexed citations
14.
Kobashigawa, Jon, et al.. (1992). Initial success of steroid weaning late after heart transplantation.. PubMed. 11(2 Pt 2). 428–30.25 indexed citations
Kobashigawa, Jon, L W Stevenson, J. Moriguchi, et al.. (1990). Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.. PubMed. 82(5 Suppl). IV281–3.53 indexed citations
18.
Kobashigawa, Jon, Stevenson Lw, J. Moriguchi, et al.. (1989). Randomized study of high dose oral cyclosporine therapy for mild acute cardiac rejection.. PubMed. 8(1). 53–8.15 indexed citations
19.
Allen, Bradley S., Gerald D. Buckberg, Lawrence A. Yeatman, et al.. (1986). STUDIES OF CONTROLLED REPERFUSION AFTER ISCHEMIA. Journal of Thoracic and Cardiovascular Surgery. 92(3). 636–648.55 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.